Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-400-1 | CAS number: 576-26-1
Carcinogenicity
Administrative data
Description of key information
This endpoint was waived on the basis that 2,6-xylenol is non-mutagenic and did not result in hyperplastic or pre-neoplastic lesions in oral repeat dose studies.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No. 1272/2008, the substance does not require classification with respect to carcinogenicity.
Additional information
According to Annex X, a carcinogenicity study may be required if the substance has a widespread dispersive use or there is evidence of frequent or long-term human exposure and the substance is classified as category 3 mutagen or there is evidence from the repeated dose study(ies) that the substance is able to induce hyperplasia and/or pre-neoplastic lesions. Based on the available data, 2,6-xylenol is not classified as a mutagen and evidence from repeat dose oral studies does not indicate that it would induce hyperplasia and/or pre-neoplastic lesions.
Supporting information is submitted in the form of a poor quality study that was awarded a reliability score of 3 in accordance with the criteria for assessing data quality as set forth by Klimisch et al. (1997).
This is a non-guideline, non-GLP study with limited details on methodology and results. A skin painting study was carried out in Sutter mice using benzene as a vehicle, which is in itself carcinogenic.
Thirty mice were exposed to the test material as a 10 % solution in benzene diluent twice weekly for 20 weeks.
8% of survivors developed papillomas at 20 weeks; none developed carcinomas by 28 weeks. According to the EPA classification (U.S. EPA. 1986), this compound would be classified in category D, meaning that there is inadequate evidence to assess the human carcinogenic potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
